Stephen F. Mahoney Viridian Therapeutics, Inc.\De (VRDN) insider trading activity

Stephen F. Mahoney is President and CEO of Viridian Therapeutics, Inc.\DE. Currently has a direct ownership of 21,400 shares of VRDN, which is worth approximately $423,506. The most recent transaction as insider was on Sep 27, 2024, when has been sold 21,400 shares (Common Stock) at a price of $23.33 per share, resulting in proceeds of $499,261. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.4K

n/a 3M change

n/a 12M change

Total Value Held $423,506

Stephen F. Mahoney Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Sep 27 2024	BUY Open market or private purchase	$499,261 $23.33 p/Share	21,400 Added 50.0%	21,400 Common Stock

Also insider at

MGTA

Magenta Therapeutics, Inc. Healthcare

Officer

SFM